Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Systemic mastocytosis associated with chronic myelomonocytic leukemia and xanthogranuloma.

Tschandl P, Müllauer L, Kittler H.

Dermatol Pract Concept. 2012 Jul 31;2(3):203a03. doi: 10.5826/dpc.0203a03. Print 2012 Jul.

2.

Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia.

Sotlar K, Marafioti T, Griesser H, Theil J, Aepinus C, Jaussi R, Stein H, Valent P, Horny HP.

Mol Pathol. 2000 Aug;53(4):188-93.

3.

Symptomatic response to imatinib mesylate in cutaneous mastocytosis associated with chronic myelomonocytic leukemia.

Vannorsdall EJ, Collins JA, Chen QC, Sarai G, Baer MR.

Curr Oncol. 2013 Aug;20(4):e349-53. doi: 10.3747/co.20.1301.

4.

Systemic mastocytosis with acute myelomonocytic leukemia: a case report.

Kar R, Rao S, Pati HP.

Indian J Hematol Blood Transfus. 2008 Dec;24(4):182-5. doi: 10.1007/s12288-008-0044-5. Epub 2009 Jan 11.

5.

Clinical and biologic diversity of leukemias occurring in patients with mastocytosis.

Sperr WR, Horny HP, Lechner K, Valent P.

Leuk Lymphoma. 2000 May;37(5-6):473-86. Review.

PMID:
11042508
6.

Chronic myelomonocytic leukemia: The role of bone marrow biopsy immunohistology.

Orazi A, Chiu R, O'Malley DP, Czader M, Allen SL, An C, Vance GH.

Mod Pathol. 2006 Dec;19(12):1536-45. Epub 2006 Oct 13.

7.

Systemic mastocytosis associated with chronic myelomonocytic leukemia: clinical features and response to interferon alfa therapy.

Petit A, Pulik M, Gaulier A, Lionnet F, Mahe A, Sigal M.

J Am Acad Dermatol. 1995 May;32(5 Pt 2):850-3.

PMID:
7722042
9.

Bone marrow findings in systemic mastocytosis.

Horny HP, Parwaresch MR, Lennert K.

Hum Pathol. 1985 Aug;16(8):808-14.

PMID:
3860469
10.

Cutaneous xanthogranulomas, hepatosplenomegaly, anemia, and thrombocytopenia as presenting signs of juvenile myelomonocytic leukemia.

Cham E, Siegel D, Ruben BS.

Am J Clin Dermatol. 2010;11(1):67-71. doi: 10.2165/11311130-000000000-00000.

PMID:
20000879
11.

Ph-Chromosome-positive chronic myeloid leukemia with associated bone marrow mastocytosis.

Agis H, Sotlar K, Valent P, Horny HP.

Leuk Res. 2005 Oct;29(10):1227-32.

PMID:
16111540
12.

Systemic mastocytosis in association with chronic lymphocytic leukemia and plasma cell myeloma.

Du S, Rashidi HH, Le DT, Kipps TJ, Broome HE, Wang HY.

Int J Clin Exp Pathol. 2010 Apr 23;3(4):448-57.

13.
14.

Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis.

Sotlar K, Cerny-Reiterer S, Petat-Dutter K, Hessel H, Berezowska S, Müllauer L, Valent P, Horny HP.

Mod Pathol. 2011 Apr;24(4):585-95. doi: 10.1038/modpathol.2010.224. Epub 2010 Dec 24.

15.

An unusual case of systemic mastocytosis associated with chronic lymphocytic leukaemia (SM-CLL).

Horny HP, Sotlar K, Stellmacher F, Valent P, Grabbe J.

J Clin Pathol. 2006 Mar;59(3):264-8.

16.

Numbers of colony-forming progenitors in patients with systemic mastocytosis: potential diagnostic implications and comparison with myeloproliferative disorders.

Jordan JH, Jäger E, Sperr WR, Schwarzinger I, Födinger M, Fritsche-Polanz R, Ohler L, Geissler K, Valent P.

Eur J Clin Invest. 2003 Jul;33(7):611-8.

PMID:
12814399
18.
19.

RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.

Ricci C, Fermo E, Corti S, Molteni M, Faricciotti A, Cortelezzi A, Lambertenghi Deliliers G, Beran M, Onida F.

Clin Cancer Res. 2010 Apr 15;16(8):2246-56. doi: 10.1158/1078-0432.CCR-09-2112. Epub 2010 Apr 6.

20.

Death from mast cell leukemia: a young patient with longstanding cutaneous mastocytosis evolving into fatal mast cell leukemia.

Chantorn R, Shwayder T.

Pediatr Dermatol. 2012 Sep-Oct;29(5):605-9. doi: 10.1111/j.1525-1470.2011.01650.x. Epub 2012 Feb 14.

PMID:
22329485
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk